Potential late-onset Alzheimer's disease-associated mutations in the ADAM10 gene attenuate {alpha}-secretase activity. - AlzForum Alzheimer Research Paper of the Week


	Current Papers
	ARF Recommends
	Milestone Papers
	Search All Papers
	Search Comments


	Research News
	Drug News
	Conference News


	AD Hypotheses
		AlzSWAN
		Current Hypotheses
		Hypothesis Factory
	Forums
		Live Discussions
		Virtual Conferences
		Interviews
	Enabling Technologies
		Workshops
		Research Tools
	Compendia
		AlzGene
		AlzRisk
		Antibodies
		Biomarkers
		Mutations
		Protocols
		Research Models
		Video Gallery
	Resources
		Bulletin Boards
		Conference Calendar
		Grants
		Jobs


	Overview
	Diagnosis/Genetics
	Research
	News
	Profiles
	Clinics


	Companies
	Tutorial
	Drugs in Clinical Trials


	About Alzheimer's
		FAQs
	Diagnosis
		Clinical Guidelines
		Tests
		Brain Banks
	Treatment
		Drugs and Therapies
	Caregiving
		Patient Care
		Support Directory
		AD Experiences


	Member Directory
	Researcher Profiles
	Institutes and Labs


	Mission
	ARF Team
	ARF Awards
	Advisory Board
	Sponsors
	Partnerships
	Fan Mail
	Support Us

Home: Papers of the Week

Annotation

	Kim M, Suh J, Romano D, Truong MH, Mullin K, Hooli B, Norton D, Tesco G, Elliott K, Wagner SL, Moir RD, Becker KD, Tanzi RE. Potential late-onset Alzheimer's disease-associated mutations in the ADAM10 gene attenuate {alpha}-secretase activity. Hum Mol Genet. 2009 Oct 15;18(20):3987-96. PubMed Abstract, View on AlzGene

	Comments on Paper and Primary News

	Comment by: Abraham Fisher
	Submitted 27 July 2009 \| Permalink	Posted 29 July 2009
	I recommend this paper

	Primary News: More AD Genetics—A Familial Hit from the ADAMs Family Comment by: Rudy Tanzi (Disclosure)
	Submitted 14 August 2009 \| Permalink	Posted 15 August 2009
	To further clarify, the two mutations were present in seven out of ~1300 AD families screened. Only two unaffecteds from two different families were mutations carriers (one for each mutation). Thus, we concluded that these mutations are partially penetrant. However, it is still possible that the affection status of either of those those two subjects could change over time. Within the seven families, the two mutations increased risk by 3.5 to ~5-fold. While these O.R.'s are a little greater than that conferred by one copy of ApoE4, these are exceedingly rare familial mutations, not common polymorphisms. Thus, they exert a smaller overall effect on the genetic variance of late-onset AD than ApoE4. View all comments by Rudy Tanzi

	Primary News: More AD Genetics—A Familial Hit from the ADAMs Family Comment by: Steve Barger (Disclosure)
	Submitted 13 August 2009 \| Permalink	Posted 25 August 2009
	I wonder what these mutations do to Notch processing/signaling? ADAM10-knockout in mice is embryonic-lethal due the loss of proper Notch function. It's a bit difficult to understand how a human could survive with a 70 percent loss of Notch signaling; but maybe there are compensatory changes in this pathway. View all comments by Steve Barger

Submit a Comment on this Paper

Cast your vote and/or make a comment on this paper.

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name
*Last Name
Country or Territory:
*Login Email Address
*Password	Minimum of 8 characters
*Confirm Password
Stay signed in?

I recommend this paper

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:

*Enter the verification code you see in the picture below:

This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:	Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.

REAGENTS/MATERIAL:
Western blot analysis: For primary antibodies, mouse monoclonal anti-Aβ (6E10) (Covance) was used to detect sAPPα levels in conditioned medium. rabbit anti-APP C-terminal (A8717) (Sigma) was utilized for full-length APP and CTFs in cell lysates and mouse monoclonal anti-HA (6E2) (Cell Signaling) for HA-tagged ADAM10. Mouse monoclonal Anti-actin, pan (C-4) (Lab Vision Neo-Markers) was used as control signal for equal loading.
Aβ ELISA: Levels of Aβx-40 in cell culture media were determined using a human/rat Aβ-specific chemiluminescence ELISA kit (Wako Chemicals USA, Inc., VA, USA). Briefly, samples and Aβ standards were aliquoted to 96 well plates coated with monoclonal antibody against Aβ1–28 region. After overnight incubation, anti-Aβ40 specific antibody conjugated with horseradish peroxidase (HRP) was added to the captured Aβ in each well.